A new partnership between Alice\u2019s Arc, the Centre for Immuno-Oncology in the Nuffield Department of Medicine and the Sir William Dunn School of Pathology will pioneer the development of a bespoke mRNA vaccine to improve treatment outcomes for children with rhabdomyosarcoma, a rare and aggressive form of soft tissue cancer.
A major study has uncovered vital insights into the brain changes linked to treatment-resistant psychosis, offering fresh hope for earlier diagnosis and more targeted care.
A partnership with Clario focuses on advancing the use of wearable sensors to enable more precise measurement of motor symptoms and disease progression in Parkinson's.
The Nuffield Department of Women\u2019s & Reproductive Health is pleased to announce that applications are now open for two new postgraduate taught courses, commencing in Michaelmas Term 2026. Both courses further strengthen our department\u2019s commitment to advancing knowledge and practice in reproductive and women\u2019s health worldwide.
The study, led by researchers at the MRC Translational Immune Discovery Unit and the CAMS Oxford Institute (NDM), found that dominant T cell responses found in many individuals 4 years after infection are associated with mild COVID-19 disease, and likely play important protective roles in subsequent viral infection events.
Oxford\u2019s first Neurodiversity Conference brought together clinicians, researchers, local organisations members of the public and the neurodivergent community to discuss current and future research and areas for potential collaboration.
Universidad Peruana Cayetano Heredia (UPCH) in Lima, Peru and the University of Oxford have secured a prestigious Discovery Award worth $3.1 million to launch a four-year programme aimed at improving treatment for Chronic Mountain Sickness (CMS)\u2014a debilitating, neglected condition affecting high-altitude populations.
PediSEP-1, a new study funded by the EDCTP3 Horizon programme, has launched to combat antimicrobial resistance (AMR) in African hospitals. The initiative introduces a risk-differentiated care approach identifying low-risk children who can be safely discharged early with minimal or no antibiotics supported by targeted parental education and \u2018virtual ward\u2019 follow up by phone. The project seeks to reduce antibiotic overuse and AMR transmission, and increase system efficiency
University of Oxford researchers have uncovered surprising new insights into how the pancreas adapts during pregnancy to meet the body\u2019s increased demand for insulin. Their findings, published in Nature Communications, challenge long-standing assumptions based on animal studies and highlight key differences between human and mouse biology.
New research shows GP retention depends on how services are organised, not just individual resilience. Meaningful work, strong relationships, and learning cultures help GPs stay in post and deliver better patient care.
The University of Oxford has announced a gift of \u00a310 million from the Bukhman Foundation to support ground-breaking research into type 1 diabetes (T1D). This generous funding will establish the Bukhman Centre for Research Excellence in Type 1 Diabetes, as well as create new academic posts and scholarships, helping to accelerate progress towards better treatments and ultimately a cure.
A new project led by Oxford University aims to develop a novel breathing test that could detect asthma and COPD earlier, more accurately, and closer to home - reducing pressure on the NHS and improving outcomes for patients.
Any amount of alcohol consumption may increase risk of dementia, according to the most comprehensive study of alcohol consumption and dementia risk to date.
Current evidence does not support a causal link between paracetamol use in pregnancy and autism spectrum disorder. A 2025 review of pivotal studies concluded that in-utero exposure to paracetamol is unlikely to confer a clinically important increased risk of ASD, and clinical guidelines on treating pain and fever in pregnancy should not change. Untreated pain and fever can harm both mother and fetus; when needed, paracetamol remains the recommended option.
A new study has found the current recommended treatment for Chagas disease could be given over a substantially shorter time period and still be as effective.
In the largest study of its kind, new global research has revealed that drug shortages can become a systemic issue affecting the health of millions of patients and impacting healthcare systems in Europe and North America
People with severe mental illness gain 4kg more weight than peers over 15 years but aren't offered more weight-management support, identifying crucial five-year intervention window.
![\"Alice's](\"https://www.medsci.ox.ac.uk/news/nuffield-department-of-medicine-scientists-receive-funding-for-childrens-cancer-vaccine-development/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n